TO7.F Toyobo Co. Ltd
- Market cap
- EUR 759M
- P/E
- 15.6x
- P/B
- 0.62x
- ROE
- 5.2%
- Dividend yield
- 2.67%
- Fundamental score
- -
Ratios use the latest price and the fiscal year ending Mar 2026.
Is TO7.F undervalued?
Graham numberTO7.F trades 34.2% below its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Toyobo Co. Ltd fundamental analysis
No fundamental analysis for Toyobo Co. Ltd yet.
Toyobo Co. Ltd stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Toyobo Co. Ltd
Toyobo Co., Ltd., together with its subsidiaries, manufactures, processes, and sells various films, life sciences, environmental and functional materials, and fibers and textiles products in Japan, China, Southeast Asia, and internationally. It operates through five segments: Film; Life Science; Environmental and Functional Materials; Functional Fibers and Trading; and Real Estate. The company offers industrial films for liquid crystal polarizers, displays, synthetic paper, …
Full company profileToyobo Co. Ltd financial statements
Toyobo Co. Ltd annual financial statements (JPY; K = thousand, M = million, B = billion, T = trillion)
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||
| Revenue | 329B | 331B | 337B | 340B | 337B | 376B | 400B | 414B | 422B | 422B |
| Gross Profit | 79.5B | 81.1B | 81.1B | 84.5B | 90.4B | 96.1B | 85.0B | 88.0B | 97.1B | 108B |
| Operating Income | 23.3B | 23.9B | 21.7B | 22.8B | 26.7B | 28.4B | 10.1B | 9.00B | 16.7B | 27.9B |
| EBITDA | - | 35.2B | 17.2B | 38.1B | 26.0B | 36.1B | 21.0B | 26.7B | 32.0B | 46.9B |
| Net Income | 9.44B | 13.0B | -603M | 13.8B | 4.20B | 12.9B | -655M | 2.46B | 2.00B | 11.2B |
| EPS | 106 | 147 | -6.79 | 155 | 47 | 145 | -7.42 | 28 | 23 | 127 |
| Balance Sheet | ||||||||||
| Total Assets | 451B | 446B | 461B | 489B | 491B | 518B | 589B | 607B | 618B | 628B |
| Total Liabilities | 280B | 262B | 280B | 306B | 303B | 321B | 367B | 377B | 386B | 376B |
| Shareholders' Equity | 168B | 181B | 177B | 178B | 186B | 195B | 190B | 197B | 195B | 213B |
| Cash & Short-term Investments | 32.3B | 26.0B | 22.3B | 25.2B | 34.7B | 27.2B | 60.7B | 33.8B | 28.6B | 31.1B |
| Cash Flow | ||||||||||
| Operating Cash Flow | 26.9B | 22.4B | 7.84B | 44.3B | 35.0B | 17.1B | 7.80B | 21.6B | 30.1B | 45.0B |
| Capital Expenditure | 17.2B | 20.7B | 24.2B | 30.9B | 27.5B | 29.1B | 39.2B | 56.6B | 45.2B | 29.2B |
| Free Cash Flow | - | 1.66B | -16.4B | 13.4B | 7.53B | -12.0B | -31.4B | -35.0B | -15.1B | 15.9B |
| Ratios | ||||||||||
| ROE | 5.6% | 7.2% | -0.3% | 7.7% | 2.3% | 6.6% | -0.3% | 1.2% | 1.0% | 5.2% |
| ROA | 2.1% | 2.9% | -0.1% | 2.8% | 0.9% | 2.5% | -0.1% | 0.4% | 0.3% | 1.8% |
| Net Profit Margin | 2.9% | 3.9% | -0.2% | 4.1% | 1.2% | 3.4% | -0.2% | 0.6% | 0.5% | 2.7% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Toyobo Co. Ltd dividends
- Dividend yield
- 2.67%
- Forward dividend
- 0.23 EUR
- Payout ratio
- 31.5%
- Ex-dividend date
- Mar 30, 2027
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2026 | JPY 3.52B | 40 | 31.5% |
| 2025 | JPY 3.53B | 40 | 176.0% |
| 2024 | JPY 3.53B | 40 | 143.8% |
| 2023 | JPY 3.56B | 40 | - |
| 2022 | JPY 3.55B | 40 | 27.6% |
| 2021 | JPY 3.55B | 40 | 84.5% |
| 2020 | EUR 3.55B | 40 | 25.8% |
| 2019 | EUR 3.55B | 40 | - |
| 2018 | EUR 3.11B | 35 | 23.9% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 1:10 on Sep 27, 2017.
Who owns Toyobo Co. Ltd
- Insiders 5.56%
- Institutions 32.06%
- Public & others 62.38%
- Shares outstanding 88.2M
- Free float 83.4M
Toyobo Co. Ltd company profile
- Company name
- Toyobo Co. Ltd
- Ticker
- TO7.F
- ISIN
- JP3619800000
- Exchange
- Frankfurt Exchange
- Sector
- Basic Materials
- Industry
- Chemicals
- Employees
- 9,398
- Fiscal year end
- March
- Address
- Osaka Umeda Twin Towers South, Kita, Japan, 530-0001
- Phone
- 81 6 6348 3111
- Website
- toyobo-global.com
About Toyobo Co. Ltd
Toyobo Co., Ltd., together with its subsidiaries, manufactures, processes, and sells various films, life sciences, environmental and functional materials, and fibers and textiles products in Japan, China, Southeast Asia, and internationally. It operates through five segments: Film; Life Science; Environmental and Functional Materials; Functional Fibers and Trading; and Real Estate. The company offers industrial films for liquid crystal polarizers, displays, synthetic paper, labels, and ceramic capacitors; and packaging films for food packaging and other products. It also provides hollow fiber membranes for artificial kidneys and food, beverage, and industrial membranes; antithrombogenic polymers, nerve regeneration guidance conduits, and bone void fillers with collagen; contract manufacturing of injections, contract packaging, and contract testing; enzymes for diagnostic reagent, reagents for life science research, and IVD devices and reagents; and cosmetics ingredients. In addition, the company offers engineering plastics and elastomer; filter materials, equipment and device systems, and bag filters; reverse osmosis membrane modules; cushion materials for seatings, mattresses, and bedclothes; recycled polyester staple fibers and polyester spunbonds; polyethylene and PBO fibers; industrial adhesives and coatings, as well as water-wash letterpress plates; and fine chemicals and pharmaceutical intermediates. Further, it is involved in the provision of industrial fibers and civil materials, comfort evaluation technology, airbag fabrics, adhesives and coating materials, and clothing fiber functional materials; and rental and management of real estate properties. The company was founded in 1882 and is headquartered in Kita, Japan.
Toyobo Co. Ltd management
10- Mr. Seiji NaraharaExecutive Chairman · born 1956
- Mr. Ikuo TakeuchiPresident, CEO, Head of Internal Audit, Co-COO & Representative Director · born 1962
- Hidekazu TakahashiExecutive Officer & CFO
- Mr. Taichi SakaiSenior Managing Exec. Officer, Co-COO & Rep. Director · born 1962
- Mr. Masanao KudoManaging Executive Officer, Co-COO, Head of Films Division & GM of Tokyo Branch
- Toshiyuki OyaCTO and Executive Officer of Research & Business Development Division
- Takeshi MochizukiManager of Investor Relations Group & Corporate Communication Department
- Mr. Takehiko InadaManaging Executive Officer, GM of Human Resources, General Affairs & Legal Dept. · born 1965
- Mr. Takayuki TaboDirector · born 1961
- Masakazu IwasakiManaging Executive Officers & Head of Quality Assurance Division